Xinrong Xiang

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0002-0629-5343

发表论文 26 篇 · 总被引 255 次 · h-index 10

代表论文

• Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties (2023 · Science Translational Medicine · 被引 57)
• Repurposing antiparasitic antimonials to noncovalently rescue temperature-sensitive p53 mutations (2022 · Cell Reports · 被引 38)
• Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials (2020 · Frontiers in Pharmacology · 被引 24)
• Rational Design of a Novel Class of Human ClpP Agonists through a Ring-Opening Strategy with Enhanced Antileukemia Activity (2024 · Journal of Medicinal Chemistry · 被引 21)
• Epigenetic changes in Mycobacterium tuberculosis and its host provide potential targets or biomarkers for drug discovery and clinical diagnosis (2022 · Pharmacological Research · 被引 20)
• Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study (2024 · Annals of Hematology · 被引 17)